The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay

American Journal of Clinical Pathology

Volumn 111, Issue 3, 1999, Pages 355-362

  Olsen, Karen Ege ^a   Sletten, Knut ^b   Westermark, Per ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

AA amyloidosis; AL amyloidosis; ELISA; Light chain; Subcutaneous fat tissue; Transthyretin; ,

Indexed keywords

AMYLOIDOSIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SUBCUTANEOUS FAT;

EID: 0033035051     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.3.355     Document Type: Article

References (37)

1. Westermark P. Diagnosing amyloidosis. Scand J Rheumatol. 1995;24:327-329.
2. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522-523.
3. Linke RP, Gärtner HV, Michels H. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits. J Histochem Cytochem. 1995;43:863-869.
4. Cornwell GG III, Thomas B, Kyle RA, et al. Clinicopathologic correlations in 109 patients with systemic amyloidosis studied by immunocytochemistry. In: Natvig J, Førre Ø, Husby G, et al, eds. Amyloid and Amyloidosis 1990. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1991:203-206.
5. Westermark P, Stenkvist B, Natvig JB, et al. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis. 1979;38:68-71.
6. Gallo G, Kaakour M, Kumar A, et al. Immunohistologic classification of systemic amyloidosis by fat aspiration biopsy. Int Exp Clin Invest. 1994;1:94-99.
7. Kaplan B, German G, Ravid M, et al. Determination of amyloid subtype by ELISA using milligram amounts of tissue. Clin Chim Acta. 1994;229:171-179.
8. Olsen KE, Sandgren O, Sletten K, et al. Primary localized amyloidosis of the eye-lid: two cases of immunoglobulin light chain-derived amyloid proteins, subtype λV respectively λVI. Clin Exp Immunol. 1996;106:362-366.
9. Gutkowska J, Januszewicz P, Cantin M, et al. Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun. 1984;122:593-601.
10. Gustavsson Å, Engström U, Westermark P. Mechanisms of transthyretin (TTR) amyloidogenesis: antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localization. Am J Pathol. 1994;144:1301-1311.
11. Toft KG, Olstad OK, Sletten K, et al. Comparative studies of two AL chains of kappa-III light chain origin with and without attached carbohydrate (ALSo124 and AL700). In: Natvig JB, Førre Ø, Husby G, et al, eds. Amyloid and Amyloidosis 1990. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1991:169-172.
12. Engvig JP, Olsen KE, Gislefoss RE, et al. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol. 1998;48:92-98.
13. Pras M, Zucker-Franklin D, Rimon A, et al. Physical, chemical and ultrastructural studies of water-soluble amyloid fibrils: comparative analysis of nine amyloid preparations. J Exp Med. 1969;130:777-795.
14. Pras M, Schubert M, Zucker-Franklin D, et al. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968;47:924-933.
15. Westermark P, Natvig JB, Anders RF, et al. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils. Scand J Immunol. 1976;5:31-36.
16. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10:355-364.
17. Westermark P, Benson L, Juul J, et al. Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis. J Clin Pathol. 1989;42:817-819.
18. Blobel G, Dobberstein B. Transfer of proteins across membranes, I: presence of proteolytically processed and nonprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Biol Chem. 1975;67:835-851.
19. Bergman T, Jörnvall H. Electroblotting of individual polypeptides from SDS/polyacrylamide gels for direct sequence analysis. Eur J Biochem. 1987;169:9-12.
20. Westermark P, Sletten K, Johansson B, et al. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A. 1990;87:2843-2845.
21. Hermansen L, Juul J, Sletten K. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and centrifuge blotting: preparation of polypeptides for amino-terminal sequence analysis. Electrophoresis. 1996;14:1302-1306.
22. Kabat EH, Wu TT, Perry HM, et al. Sequences of Proteins of Immunological Interest. 5th ed. Bethesda, Md: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1991.
23. Merlini G. Treatment of primary amyloidosis. Semin Hematol. 1995;32:60-79.
24. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med. 1983;143:1549-1552.
25. Orfila C, Giraud P, Modesto A, et al. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol. 1986;17:366-369.
26. Duston MA, Skinner M, Shirahama T, et al. Diagnosis of amyloidosis by abdominal fat aspiration. Am J Med. 1987;82:412-414.
27. Maruyama K, Ikeda S, Yanagisawa N, et al. Diagnostic value of abdominal fat tissue aspirate in familial amyloidotic polyneuropathy. J Neurol Sci. 1987;81:11-18.
28. Gertz MA, Li CY, Shirahama T, et al. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929-933.
29. Päi S, Helin H, Isomäki H. Frequency of amyloidosis in Estonian patients with rheumatoid arthritis. Scand J Rheumatol. 1993;22:248-249.
30. Masouyé I. Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: an analysis of 100 cases. Am J Dermatopathol. 1997;19:41-45.
31. Franklin EC, Pras M. Immunologic studies of water-soluble human amyloid fibrils. J Exp Med. 1969;130:797-808.
32. Bellotti V, Merlini G. Current concepts on the pathogenesis of systemic amyloidosis. Nephrol Dial Transplant. 1996;11:53-62.
33. Linke RP. An antiserum against the λ-Bence-Jones protein ZIM having idiotypic and C-region specificity does not immunostain the Aλ(ZIM) amyloid fibrils in tissue sections. In: Kisilevsky R, Benson MD, Frangione B, et al, eds. Amyloid and Amyloidosis. New York, NY: Parthenon Publishing Group; 1993;253-255.
34. Klafki H, Pick A, Pardowitz I, et al. Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro. Biol Chem Hoppe-Seyler. 1993;374:1117-1122.
35. Terry W, Page D, Kimura S, et al. Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest. 1973;52:1276-1281.
36. Olsen KE, Sletten K, Westermark P. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun. 1998;251:642-647.
37. Varga J, Idelson B, Felson D, et al. Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med. 1987;147:1455-1457.